Kaushal Mohit
SEC Form 4 insider trading activity
Kaushal Mohit has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jul 29, 2026.
On the most recent filing, Kaushal Mohit is listed as Director at Oncology Institute, Inc. Inside the rolling window, Kaushal Mohit reported no open-market purchases and 2 open-market sales totaling $335K in TOI. The largest disclosed transaction in the window is a sale of 57,286 TOI shares on Apr 14, 2026, worth $201K.
Companies traded
Other insiders at TOI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$335K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kaushal Mohit made?
Kaushal Mohit has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Kaushal Mohit trade?
Kaushal Mohit has filed SEC Form 4 disclosures for 1 company, including TOI.
When was Kaushal Mohit's most recent SEC Form 4 filing?
Kaushal Mohit's most recent SEC Form 4 filing on Tracefour is dated Jul 29, 2026.
What is Kaushal Mohit's total buy and sell value in the current window?
Inside the rolling retention window, Kaushal Mohit bought $0 and sold $335K based on SEC Form 4 filings.
What was Kaushal Mohit's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 57,286 TOI shares on 2026-04-14, worth $201K, per SEC Form 4 filings.